第一单位：
The Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. dawn.maze@uhn.ca.
作者：
Dawn,Maze [1]
;
Murat O,Arcasoy [2]
;
Ryan,Henrie [3]
;
Sonia,Cerquozzi [4]
;
Rammurti,Kamble [5]
;
Samer,Al-Hadidi [6]
;
Abdulraheem,Yacoub [7]
;
Anurag K,Singh [7]
;
Mahmoud,Elsawy [8]
;
Shireen,Sirhan [9]
;
Elliot,Smith [10]
;
Curtis,Marcoux [8]
;
Auro,Viswabandya [10]
;
Andrew,Daly [4]
;
Hassan,Sibai [10]
;
Caroline,McNamara [10]
;
Yuliang,Shi [11]
;
Wei,Xu [12]
;
Katherine,Lajkosz [12]
;
Lynda,Foltz [3]
;
Vikas,Gupta [10]
作者单位：
The Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. dawn.maze@uhn.ca.
[1]
Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA.
[2]
Division of Hematology, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
[3]
Tom Baker Cancer Centre, Alberta Health Service Calgary Zone, University of Calgary, Calgary, AB, Canada.
[4]
Center for Cell and Gene Therapy, Baylor College of Medicine and Houston Methodist Hospital, Houston, TX, USA.
[5]
Myeloma Section, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
[6]
Division of Hematology and Oncology, University of Kansas Medical Center, Kansas City, KS, USA.
[7]
Division of Hematology, Dalhousie University, Halifax, NS, Canada.
[8]
Jewish General Hospital, McGill University, Montreal, QC, Canada.
[9]
The Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
[10]
Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.;Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada.
[11]
Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.;Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
[12]
DOI
10.1038/s41409-023-02194-y
PMID
38279008
发布时间
2024-02-10
换一批
